MARLBOROUGH, Mass.–(BUSINESS WIRE)–#earnings–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2019 on Wednesday, November 6, 2019, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialing 888-204-4368 (in the United States) or +1 323-994-2093 (for international callers) and referencing access code 1855427. Participants should dial in 5-10 minutes before the call begins. A replay will be available approximately two hours after the call ends through Friday, November 29, 2019. The replay numbers are 888-203-1112 (U.S.) or +1 719-457-0820 (international), access code 1855427, PIN 2953.
Hologic will provide a live webcast of the call on the Company’s website at www.investors.hologic.com.
The call will be archived there for 30 days.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
SOURCE: Hologic, Inc.
Contacts
Paula Izidoro
Senior Investor Relations Specialist
(858) 410-8904
paula.izidoro@hologic.com
PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a…
Prostate Volume Assist (PVA) is the company’s proprietary urology-based artificial intelligence (AI) software feature designed…
PITTSBURGH & SACRAMENTO, Calif.--(BUSINESS WIRE)--Today, Abridge and Sutter Health announced they will make Abridge’s generative…
Presentations Will Feature Studies Evaluating TENEO™ Excimer Laser Platform, MIEBO® (Perfluorohexyloctane Ophthalmic Solution) and enVista®…
Blackstone Life Sciences to invest up to $750 million to support innovative mRNA technologyNEW YORK--(BUSINESS…
Phase 1a study of first hormone-free male pill completes enrollmentDURHAM, NC / ACCESSWIRE / March…
